KITLG and amyloidosis: Considering SCF is one inflammatory entity that is differentially expressed in the serum and CSF of 1 wk ABX gvg-treated APPSWE/PS1ΔE9 mice, further compartmental-based investigations are required to elucidate the impact of these altered inflammatory profiles on neuro-inflammation and amyloidosis.